Inhibition of nitric oxide synthase induces a selective reduction in tumor blood flow that is reversible with L-arginine.

No abstract is available for this paper.

• Publication year

  1997

• Venue

  Cancer Research

• Publication date

  1997-03-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  PMID 9041200
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Selective pharmacological inhibition of distinct nitric oxide synthase isoforms.

  1996cited by this paper
• NG-nitro-L-arginine methyl ester, an inhibitor of nitric oxide synthesis, ameliorates interleukin 2-induced capillary leakage and reduces tumour growth in adenocarcinoma-bearing mice.

  1996cited by this paper
• Excessive production of nitric oxide in rat solid tumor and its implication in rapid tumor growth

  1996cited by this paper
• The role of nitric oxide in the central control of blood pressure.

  1995cited by this paper
• Nitric oxide synthase activity in human breast cancer.

  1995cited by this paper
• Nitric oxide synthase inhibition irreversibly decreases perfusion in the R3230Ac rat mammary adenocarcinoma.

  1995cited by this paper
• Immunohistochemical characterization of nitric oxide synthase activity in squamous cell carcinoma of the head and neck.

  1995cited by this paper
• The influence of nitric oxide on tumour vascular tone.

  1995cited by this paper
• Expression of nitric oxide synthase in human central nervous system tumors.

  1995cited by this paper
• Cardiac and regional haemodynamics, inducible nitric oxide synthase (NOS) activity, and the effects of NOS inhibitors in conscious, endotoxaemic rats

  1995cited by this paper
• Immunohistochemical characterizationof nitric oxide synthase activity in squamous cell carcinoma of the head and neck

  1995cited by this paper
• Characterisation of tumour blood flow using a 'tissue-isolated' preparation.

  1994cited by this paper
• Understanding the controversy over the identity of EDRF

  1994cited by this paper
• Vasodilator effect of carboxy-2-phenyl-4,4,5,5-tetramethylimidazoline-1-oxyl in the coronary circulation: in vivo and in vitro studies.

  1994cited by this paper
• Aberrant expression of nitric oxide synthase in human polyps, neoplastic colonic mucosa and surrounding peritumoral normal mucosa.

  1994cited by this paper
• Induction of hypoxia in experimental murine tumors by the nitric oxide synthase inhibitor, NG-nitro-L-arginine.

  1994cited by this paper
• Multiple functions of nitric oxide in pathophysiology and microbiology: analysis by a new nitric oxide scavenger

  1994cited by this paper
• Enhanced Vascular Permeability in Solid Tumor Is Mediated by Nitric Oxide and Inhibited by Both New Nitric Oxide Scavenger and Nitric Oxide Synthase Inhibitor

  1994cited by this paper
• Nitric oxide synthase activity in human gynecological cancer.

  1994cited by this paper
• Therapeutic effects of imidazolineoxyl N-oxide against endotoxin shock through its direct nitric oxide-scavenging activity.

  1994cited by this paper
• Modification of metabolism of transplantable and spontaneous murine tumors by the nitric oxide synthase inhibitor, nitro-L-arginine.

  1994cited by this paper
• Role of NO in vascular smooth muscle and cardiac muscle function.

  1994cited by this paper
• Induction of iron-derived EPR signals in murine cancers by nitric oxide. Evidence for multiple intracellular targets.

  1994cited by this paper
• Reduction in tumor blood flow in skin flap tumor after hydralazine is not due to a vascular steal phenomenon

  1993cited by this paper
• Tumour blood flow: measurement and manipulation for therapeutic gain.

  1993cited by this paper
• Induction of nitric oxide synthase in the neo‐vasculature of experimental tumours in mice

  1993cited by this paper
• Microvascular mechanisms of change in tumor blood flow due to angiotensin II, epinephrine, and methoxamine: a functional morphometric study.

  1993cited by this paper
• Modification of tumour blood flow using the hypertensive agent, angiotensin II.

  1993cited by this paper
• Modification of energy metabolism and radiation response of a murine tumour by changes in nitric oxide availability.

  1993cited by this paper
• Inhibitors of nitric oxide synthase selectively reduce flow in tumour‐associated neovasculature

  1992cited by this paper
• Relationship between the hydralazine-induced changes in murine tumor blood supply and mouse blood pressure.

  1992cited by this paper
• Nitric oxide: physiology, pathophysiology, and pharmacology.

  1991cited by this paper
• Nitric oxide: an endogenous modulator of leukocyte adhesion.

  1991cited by this paper
• Modification of tumour blood flow--a review.

  1991cited by this paper
• Hydralazine-induced tumor hypoxia: a potential target for cancer chemotherapy.

  1990cited by this paper
• Blood flow and blood volume in a transplanted rat fibrosarcoma: comparison with various normal tissues.

  1990cited by this paper
• The use of hydralazine to manipulate tumour temperatures during hyperthermia.

  1990cited by this paper
• Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo

  1990cited by this paper
• The effect of hydralazine on the tumor cytotoxicity of the hypoxic cell cytotoxin RSU-1069: evidence for therapeutic gain.

  1987cited by this paper

• Leishmania guyanensis suppressed inducible nitric oxide synthase provoked by its viral endosymbiont

  2022cites this paper
• Targeting Nitric Oxide: Say NO to Metastasis

  2022cites this paper
• Reaction mechanisms relevant to the formation and utilization of [Ru(edta)(NO)] complexes in aqueous media.

  2021cites this paper
• Protective role of natural products in glioblastoma multiforme: A focus on nitric oxide pathway.

  2020cites this paper
• Interested in publishing with us ? Contact book

  2019cites this paper
• Therapeutic Implications of the Nitric Oxide Pathway in the Angiogenesis of Tumors and Inflammatory-Related Disorders

  2019cites this paper
• Experimental Investigations into Sarcomas

  2018cites this paper
• Oleanolic Acid Inhibits Epithelial–Mesenchymal Transition of Hepatocellular Carcinoma by Promoting iNOS Dimerization

  2018cites this paper
• Synergistic Activities of Nitric Oxide and Various Drugs

  2017cites this paper
• Increased Hepatic Aetivity of Inducib } e on a High-Fat Diet Nitric Oxide Synthase in Rats Fed

  2017cites this paper
• Early Actions of Anti-Vascular Endothelial Growth Factor/Vascular Endothelial Growth Factor Receptor Drugs on Angiogenic Blood Vessels.

  2017cites this paper
• A Nitric Oxide Storage and Transport System That Protects Activated Macrophages from Endogenous Nitric Oxide Cytotoxicity*

  2016cites this paper
• Quantitative Assessment of the Effect of Nitric Oxide Synthase Inhibition on Tumor Vascular Activity Using Dynamic Contrast-Enhanced Computed Tomography

  2016influential citation
• Effect of Blocking of Neuropeptide Y Y2 Receptor on Tumor Angiogenesis and Progression in Normal and Diet-Induced Obese C57BL/6 Mice

  2015cites this paper
• The Role of Nitric Oxide Synthase Uncoupling in Tumor Progression

  2015cites this paper
• Nitric oxide in cancer metastasis.

  2014cites this paper
• Université de Montréal-Thèse numérique

  2014cites this paper
• Endothelial-specific Notch blockade inhibits vascular function and tumor growth through an eNOS-dependent mechanism.

  2014cites this paper
• The Endothelial ADMA/NO Pathway in Hypoxia-Related Chronic Respiratory Diseases

  2014cites this paper
• 흰쥐의 Caspase-3, 9와 Neuronal Nitric Oxide Synthase on the Change of Caspase-3, 9 and Neuronal Nitric Oxide Synthase Immunoreactive Cells in the Sprague Dawley Rats

  2013cites this paper
• iNOS: a potential therapeutic target for malignant glioma.

  2013cites this paper
• Targeting the Tumour Vasculature: Exploitation of Low Oxygenation and Sensitivity to NOS Inhibition by Treatment with a Hypoxic Cytotoxin

  2013cites this paper
• Enhanced delivery of polymer therapeutics to solid tumors

  2013cites this paper
• Antitumor Actions of Ruthenium(III)-Based Nitric Oxide Scavengers and Nitric Oxide Synthase Inhibitors

  2011cites this paper
• Nitric Oxide Synthase Inhibition Enhances the Antitumor Effect of Radiation in the Treatment of Squamous Carcinoma Xenografts

  2011cites this paper
• The role of nitric oxide in hindlimb remote ischaemic preconditioning of the liver

  2011cites this paper
• Air Pollution and Its Effects in the Respiratory System

  2011cites this paper
• Nitric oxide: role in tumour biology and iNOS/NO-based anticancer therapies

  2011cites this paper
• Differential effects of nitric oxide on blood-brain barrier integrity and cerebral blood flow in intracerebral C6 gliomas.

  2011cites this paper
• Nitric Oxide: Perspectives and Emerging Studies of a Well Known Cytotoxin

  2010cites this paper
• Cell type specificity of lung cancer associated with nitric oxide.

  2010cites this paper
• Nitric oxide in cancer therapeutics: interaction with cytotoxic chemotherapy.

  2010cites this paper
• Targeting the tumour microenvironment : characterizing the anti-vascular effects of the hypoxic cytotoxin tirapazamine

  2010cites this paper
• The role of nitric oxide in the treatment of tumours with aminolaevulinic acid-induced photodynamic therapy.

  2010cites this paper
• Nitrosative stress as a mediator of apoptosis: implications for cancer therapy.

  2010cites this paper
• Angiogenesis in non-small cell lung cancer: imaging with perfusion computed tomography.

  2010cites this paper
• Vascular Disruptive Agents in Combination with Radiotherapy

  2010cites this paper
• Induced nitric oxide synthase as a major player in the oncogenic transformation of inflamed tissue.

  2009cites this paper
• Inducible nitric oxide synthase expression in melanoma: implications in lymphangiogenesis

  2009cites this paper
• Development of a method to quantitatively monitor the effect of inhibition of nitric oxide synthase on tumour vascular activity using dynamic contrast-enhanced computed tomography

  2009cites this paper
• Tumor-Targeted Macromolecular Drug Delivery Based on the Enhanced Permeability and Retention Effect in Solid Tumor

  2009cites this paper
• Nitric Oxide Synthase Inhibition Enhances the Tumor Vascular-Damaging Effects of Combretastatin A-4 3-O-Phosphate at Clinically Relevant Doses

  2009cites this paper
• Mechanisms of Brain Tumor Angiogenesis

  2009cites this paper
• Nitric oxide: cancer target or anticancer agent?

  2009cites this paper
• Actions and interactions of nitric oxide, carbon monoxide and hydrogen sulphide in the cardiovascular system and in inflammation--a tale of three gases!

  2009cites this paper
• Therapeutic targeting and clinical assessment of the tumour vasculature.

  2008cites this paper
• Nitric oxide--a novel therapeutic for cancer.

  2008cites this paper
• Response to Endothelin-1 in Arteries from Human Colorectal Tumours: Role of Endothelin Receptors

  2008cites this paper
• Thrombospondin 1 and vasoactive agents indirectly alter tumor blood flow.

  2008cites this paper
• Effect of nitric-oxide synthesis on tumour blood volume and vascular activity: a phase I study.

  2007cites this paper
• Nitrosative stress in cancer therapy.

  2007cites this paper
• Nitric oxide, a double edged sword in cancer biology: Searching for therapeutic opportunities

  2007cites this paper
• Targeting nitric oxide for cancer therapy

  2007cites this paper
• Dynamic Thermal Assessment

  2007cites this paper
• The role of nitric oxide in tumour progression

  2006cites this paper
• Nitric oxide mediates neurodegeneration and breakdown of the blood-brain barrier in tPA-dependent excitotoxic injury in mice

  2006cites this paper
• Inducible nitric oxide synthase (iNOS) in tumor biology: the two sides of the same coin.

  2005cites this paper
• The EPR Effect and Polymeric Drugs: A Paradigm Shift for Cancer Chemotherapy in the 21st Century

  2005cites this paper
• Ruthenium as an effective nitric oxide scavenger.

  2004cites this paper
• Metal complexes as therapeutic agents in nitrogen monoxide modulation.

  2004cites this paper
• Intracellular signaling mechanisms in photodynamic therapy.

  2004cites this paper
• Inducible Nitric Oxide Synthase as a Target for Chemoprevention

  2004cites this paper
• Role of nitric oxide in tumor angiogenesis.

  2004cites this paper
• 17-&bgr; Estradiol Independently Regulates Erythropoietin Synthesis and NOS Activity during Hypoxia

  2004cites this paper
• Metabolic and Hematological Effects of Dietary Supplementation with Arginine on Rats Bearing Ascitic Walker 256 Tumor

  2004cites this paper
• Factors and mechanism of "EPR" effect and the enhanced antitumor effects of macromolecular drugs including SMANCS.

  2003cites this paper
• The Pharmacology of Nitric Oxide in the Peripheral Nervous System of Blood Vessels

  2003cites this paper
• The use of CT perfusion to monitor the effect of hypocapnia during laser thermal therapy in a rabbit model

  2003cites this paper
• Radical causes of cancer

  2003cites this paper
• Effects of Tin-Protoporphyrin IX on Blood Flow in a Rat Tumor Model

  2003cites this paper
• Nitric oxide in cancer and chemoprevention.

  2003cites this paper
• Association Between Nitrotyrosine Levels and Microvascular Density in Human Breast Cancer

  2002cites this paper
• Nitric Oxide Modulates Tumor Cell Death Induced by Photodynamic Therapy Through a cGMP‐dependent Mechanism ¶

  2002cites this paper
• Nitric Oxide Modulates Tumor Cell Death Induced by Photodynamic Therapy Through a cGMP-dependent Mechanism¶

  2002cites this paper
• Arginase Activity is Inhibited by l -NAME, both In Vitro and In Vivo

  2002cites this paper
• The biology of the combretastatins as tumour vascular targeting agents

  2002cites this paper
• Enhancement of vascular targeting by inhibitors of nitric oxide synthase.

  2002cites this paper
• Macrophage arginine metabolism to ornithine/urea or nitric oxide/citrulline: a life or death issue.

  2001cites this paper
• Tumor suppressor genes: at the crossroads of molecular carcinogenesis, molecular epidemiology and human risk assessment.

  2001cites this paper
• Mechanisms associated with tumor vascular shut-down induced by combretastatin A-4 phosphate: intravital microscopy and measurement of vascular permeability.

  2001cites this paper
• Modulation of inducible nitric oxide synthase expression in rat intestinal cells by colon tumor promoters.

  2001cites this paper
• [Pharmacological effects of arginine supplementation in rats with Walker 256 solid tumor].

  2000cites this paper
• Increased Hepatic Activity of Inducible Nitric Oxide Synthase in Rats Fed on a High-Fat Diet

  2000cites this paper
• Expression of nitric oxide synthase isozymes (NOS I-III) by immunohistochemistry and DNA in situ hybridization. Correlation with macrophage presence, vascular endothelial growth factor (VEGF) and oedema volumetric data in 220 glioblastomas.

  2000cites this paper
• Acute pancreatitis associated with administration of a nitric oxide synthase inhibitor in tumor-bearing dogs.

  2000cites this paper
• Perspectives on cancer chemoprevention research and drug development.

  2000cites this paper
• Nitric Oxide and Angiogenesis

  2000cites this paper
• Hypoxia modulated gene expression: angiogenesis, metastasis and therapeutic exploitation.

  2000cites this paper
• Tumor‐selective Blood Flow Decrease Induced by an Angiotensin Converting Enzyme Inhibitor, Temocapril Hydrochloride

  2000cites this paper
• Nitric oxide synthase inhibition results in synergistic anti-tumour activity with melphalan and tumour necrosis factor alpha-based isolated limb perfusions

  2000cites this paper
• Pathophysiological Effects of High-Output Production of Nitric Oxide

  2000cites this paper
• Molecular epidemiology and carcinogenesis: endogenous and exogenous carcinogens.

  2000cites this paper
• Detection of inducible nitric oxide synthase (iNOS) mRNA by RT-PCR in ATL patients and HTLV-I infected cell lines: clinical features and apoptosis by NOS inhibitor

  1999cites this paper
• Induction of haem oxygenase-1 by nitric oxide and ischaemia in experimental solid tumours and implications for tumour growth

  1999cites this paper
• Differential expression of nitric oxide synthase in human stomach cancer.

  1999cites this paper
• Cycling and Bioreductive Anticancer Agents Nitric Oxide Synthases Catalyze the Activation of Redox Updated

  1999cites this paper
• Evaluation of Antivascular and Antimitotic Effects of Tubulin Binding Agents in Solid Tumor Therapy

  1999cites this paper
• Antitumor Effects due to Irreversible Stoppage of Tumor Tissue Blood Flow: Evaluation of a Novel Combretastatin A‐4 Derivative, AC7700

  1999cites this paper
• Expression of the neuronal isoform of nitric oxide synthase (nNOS) and its inhibitor, protein inhibitor of nNOS, in pigment cell lesions of the skin

  1999cites this paper
• [Effects of dietetic supplementation with L-arginine in cancer patients. A review of the literature].

  1999cites this paper